1-2 of 2
Keywords: Personalized medicine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board

Available to Purchase
Subject Area:
Further Areas
Jakob Michaelis, Ruth Himmelsbach, Patrick Metzger, Silke Lassmann, Melanie Börries, Martin Werner, Cornelius Miething, Rouven Höfflin, Anna L. Illert, Justus Duyster, Heiko Becker, August Sigle, Christian Gratzke, Markus Grabbert
Journal: Urologia Internationalis
Urol Int (2024) 108 (5): 383–391.
https://doi.org/10.1159/000538908
Published Online: 16 April 2024
...Jakob Michaelis; Ruth Himmelsbach; Patrick Metzger; Silke Lassmann; Melanie Börries; Martin Werner; Cornelius Miething; Rouven Höfflin; Anna L. Illert; Justus Duyster; Heiko Becker; August Sigle; Christian Gratzke; Markus Grabbert Introduction: Personalized medicine poses great opportunities...
View articletitled, Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board
Open the PDF for Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board in another window
Journal Articles

Bladder Tumor Heterogeneity: The Impact on Clinical Treatment

Available to Purchase
Subject Area:
Further Areas
Chao Chen, Xiang Jie Qi, Yan Wei Cao, Yong Hua Wang, Xue Cheng Yang, Shi Xiu Shao, Hai Tao Niu
Journal: Urologia Internationalis
Urol Int (2015) 95 (1): 1–8.
https://doi.org/10.1159/000370165
Published Online: 21 March 2015
..., instructions or products referred to in the content or advertisements. Tumor heterogeneity Bladder cancer Personalized medicine Therapy Bladder cancer is a serious disease endangering human heath, the incidence of which ranks ninth in systemic cancer around the world. The major treatment...
View articletitled, Bladder Tumor Heterogeneity: The Impact on Clinical Treatment
Open the PDF for Bladder Tumor Heterogeneity: The Impact on Clinical Treatment in another window